Laboratory Monitoring for Cefazolin-Associated Acute Tubular Necrosis
Monitor serum creatinine before each dose of IV cefazolin and check urinalysis with microscopy if creatinine rises, as cefazolin can cause acute tubular necrosis (ATN), though this is rare compared to other nephrotoxic antibiotics.
Baseline Laboratory Assessment
Before initiating IV cefazolin therapy, obtain:
- Serum creatinine to establish baseline renal function 1, 2
- Blood urea nitrogen (BUN) 3
- Complete blood count (CBC) 3
- Electrolytes (sodium, potassium, chloride) 1
- Urinalysis 3
The FDA label for cefazolin specifically notes that controlled studies monitoring these parameters showed no clinically significant changes in healthy volunteers receiving 1 gram four times daily for 10 days 3.
Ongoing Monitoring During Therapy
Serum Creatinine Monitoring
Check serum creatinine before each dose if the patient has risk factors for nephrotoxicity 1, 2. For patients without significant risk factors receiving cefazolin in the outpatient setting, weekly laboratory monitoring appears safe and reasonable, with only 2.7 adverse events per 1000 weekly laboratory tests identified 4.
The key distinction here is that cefazolin has a significantly lower nephrotoxicity profile than nafcillin. In a comparative study, cefazolin caused AKI in only 2% of patients versus 19% with nafcillin 5. When AKI does occur with nafcillin (a related beta-lactam), the median time to onset is 6.5 days 5, suggesting that weekly monitoring during the first 2 weeks is prudent for cefazolin, then can be extended to every 2 weeks if stable.
Urinalysis and Urine Microscopy
Obtain urinalysis with microscopy if serum creatinine rises ≥0.3 mg/dL within 48 hours or ≥50% from baseline 6. Look specifically for:
- Sterile pyuria (white blood cells without bacteria)
- Eosinophiluria (suggests acute interstitial nephritis)
- Granular casts and tubular epithelial cells (indicates ATN) 7, 6
- Proteinuria (3+ protein on dipstick warrants quantification) 8
Urine microscopy has excellent negative predictive value for clinically important intrinsic kidney injury 9. The presence of muddy brown casts or renal tubular epithelial cells strongly suggests ATN rather than prerenal azotemia 6.
Urine Chemistry Studies
If ATN is suspected based on rising creatinine and abnormal urinalysis, obtain:
- Urine sodium - expect >40 mEq/L in ATN (versus <20 mEq/L in prerenal states) 7
- Fractional excretion of sodium (FENa) - >1% suggests ATN rather than prerenal causes 6
- Spot urine protein-to-creatinine ratio if significant proteinuria is present 8
The urinary sodium/potassium ratio <1 characteristically indicates prerenal failure, while elevated urinary sodium with reduced urine nitrogen concentration and typical sediment findings confirm ATN 7.
Advanced Biomarkers (If Available)
Novel biomarkers can differentiate true tubular damage from functional changes in creatinine:
- Neutrophil gelatinase-associated lipocalin (NGAL) - urinary NGAL >220-244 mcg/g creatinine suggests ATN rather than prerenal azotemia 6
- Kidney Injury Molecule-1 (KIM-1) - elevated in tubular injury 6, 9, 6
These biomarkers are particularly valuable because serum creatinine can rise without actual tubular damage during decongestion or hemodynamic changes 9. However, NGAL measurements are not widely available in the United States for routine clinical use 6.
Risk Factors Requiring More Intensive Monitoring
Monitor more frequently (every 2-3 days initially) if the patient has:
- Pre-existing renal impairment (eGFR <60 mL/min/1.73m²) 1, 2
- Concomitant nephrotoxic medications (NSAIDs, aminoglycosides, vancomycin) 6, 10, 11
- Dehydration or volume depletion 6, 10
- Advanced age 10
- Diabetes mellitus 10
- Heart failure or cirrhosis 6
Clinical Context and Caveats
Cefazolin-induced ATN is rare. The literature contains isolated case reports rather than large series 8, 12, 13. Most reported cases involve acute interstitial nephritis rather than ATN 8. One case described nephrotic-range proteinuria (7.95 g/day) with eosinophiluria after 4 weeks of cefazolin 2g every 8 hours 8.
The pathological manifestations of beta-lactam nephrotoxicity include acute tubular necrosis, acute tubulointerstitial nephritis, and intratubular crystal obstruction 11. Cephalothin (an older cephalosporin) has documented cases of ATN with oliguric and non-oliguric patterns, elevated urine sodium, and urinary sediment changes consistent with tubular necrosis 12.
Discontinue cefazolin immediately if creatinine rises significantly or urinalysis shows evidence of tubular injury. Most patients recover renal function after drug discontinuation, though recovery may not return completely to baseline 8, 12. Consider corticosteroids (prednisone 60 mg daily with taper) if acute interstitial nephritis is suspected based on eosinophiluria 8.
Do not rely solely on creatinine. Creatinine-based definitions of AKI have limitations in sensitivity and specificity, and creatinine kinetics can be misleading in patients with extreme or variable volume status 14, 10. Urine output criteria (<0.5 mL/kg/h for >6 hours) should also be monitored 6, 14.